CLBT Cellebrite
- 17.400
- -0.040-0.23%
- 17.360
- -0.040-0.23%
Cellebrite News
Cellebrite DI Shareholders Approve All Proposals
Analysts Offer Insights on Technology Companies: Cellebrite DI (CLBT), Stratasys (SSYS) and Mitek Systems (MITK)
Cellebrite Enhances Investigative Analytics Solution With Amazon Web Services (AWS)
Cellebrite Shares Surge, Triggering Stock Issuance
Cellebrite DI Warrant Exercise Deadline Approaches
Cellebrite DI Announces Warrant Redemption Plan
Analysts Are Bullish on These Technology Stocks: Cellebrite DI (CLBT), D-Wave Quantum (QBTS)
Why Cellebrite DI Ltd. (CLBT) Might Be Well Poised for a Surge
Craig-Hallum Maintains Cellebrite(CLBT.US) With Buy Rating
Deutsche Bank Maintains Cellebrite(CLBT.US) With Buy Rating, Raises Target Price to $18
JPMorgan Adjusts Cellebrite DI Price Target to $17 From $15, Maintains Overweight Rating
Cellebrite DI Is Maintained at Overweight by JP Morgan
Express News | Cellebrite DI Shares Are Trading Higher After Multiple Firms Raised Their Respective Price Targets on the Stock
H&R Block Posts Upbeat Earnings, Joins Alibaba Group, CI&T And Other Big Stocks Moving Higher On Friday
Earnings Call: Cellebrite Reports Robust Q2 Growth With ARR up 26%
Express News | Craig-Hallum Maintains Buy on Cellebrite DI, Raises Price Target to $20
A Quick Look at Today's Ratings for Cellebrite(CLBT.US), With a Forecast Between $17 to $17
Express News | Cellebrite DI Ltd : BofA Global Research Raises Price Objective to $17 From $13
Express News | Cellebrite DI Ltd : Deutsche Bank Raises Target Price to $18 From $15
Analysts Offer Insights on Technology Companies: Coherent Corp (COHR), Cellebrite DI (CLBT) and Grab (GRAB)
Analysis
Price Target
No Data
No Data